Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase - Tabular View

Tracking Information

First Received Date ^ICMJE

September 8, 2005

Last Updated Date

September 13, 2006

Start Date ^ICMJE

May 2003

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Pain relief within 3 hours

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00162630 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Nausea
Pain on transfer
Discomfort with block placement

Original Secondary Outcome Measures ^ICMJE

Same as current

Descriptive Information

Brief Title ^ICMJE

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Official Title ^ICMJE

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Brief Summary

To evaluate the analgesic potential of an neural blockade (Fascia iliaca compartment) with local anaesthetics in patients with hip fracture immediately after arrival in the emergency department.

Detailed Description

Hip fracture patients have severe pain in the acute phase. Traditional analgesic treatment have consisted of intramuscular morphine with its associated side effects. The trial evaluates the Fascia iliaca compartment compared to regular opioid pain therapy in hip fracture patinets immediately after arrival at the emergency department.

Study Phase

Phase IV

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study

Condition ^ICMJE

Hip Fracture

Intervention ^ICMJE

Procedure: Fascia Iliaca Compartment Blockade

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

March 2006

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Primary hip fracture suspected
able to give informed consent
no substance abuse
no regular opioid therapy
no opioid treatment within the last 6 hours
morphine intolerance
allergies to local anaesthetics

Exclusion Criteria:

Fracture ruled out on x-ray

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Denmark

Administrative Information

NCT ID ^ICMJE

NCT00162630

Responsible Party

Study ID Numbers ^ICMJE

HHSG-rct-04

Study Sponsor ^ICMJE

Hvidovre University Hospital

Collaborators ^ICMJE

IMK-fonden

Investigators ^ICMJE

Study Director:

Nicolai B Foss, MD

Hvidovre University Hospital

Information Provided By

Hvidovre University Hospital

Verification Date

September 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP